| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |